Freestone Grove Partners LP Takes $48.89 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Freestone Grove Partners LP purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 96,645 shares of the healthcare conglomerate's stock, valued at approximately $48,889,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Morgan Stanley lowered their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. HSBC reaffirmed a "hold" rating and issued a $490.00 target price on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. KeyCorp cut their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Finally, Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of "Buy" and an average price target of $596.86.

UnitedHealth Group Trading Up 0.6 %

Shares of NYSE:UNH opened at $411.54 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $374.59 billion, a price-to-earnings ratio of 26.55, a PEG ratio of 1.37 and a beta of 0.61. The stock's 50-day simple moving average is $498.51 and its two-hundred day simple moving average is $531.25. UnitedHealth Group Incorporated has a 52-week low of $401.00 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.04%. UnitedHealth Group's payout ratio is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.